Press monitoring
Credit: agsandrew - Fotolia.com
Breakthrough synapse-regenerating ALS pill moves to phase 2 human trials
31.5.2024: A pioneering once-a-day pill that regenerates nerve cell connections damaged by ALS has been FDA-approved for ongoing clinical trials. The drug is now being given to those with ALS and could be a watershed moment in the treatment of the fatal disease. Spinogenix, a clinical-stage biopharmaceutical company, has developed SPG302, a unique once-a-day pill that regenerates the gaps, called synapses, between neurons to restore communication. Following promising results from clinical trials to evaluate the drug’s safety,
News of Science
7.12.2015: Currently, we solve three main tasks using Arabidopsis thaliana as model: 1. Genetic determination of metabolome pathway connected to prenylflavonoid and lupulin production in hop. 2. Study of...
Newly on Gate2Biotech
14.3.2017: More than 400 decision makers and professionals attended PHARM Connect this year from over 25 countries with the same purpose: sharing their experiences, building new partnerships, finding the best...
International cooperation
3.5.2017: A Slovenian research institute developed protein patches applicable for healing chronic skin wounds rapidly and cost efficiently. Patches are biodegradable – disappearing in the wound, leaving no...
Students
11.8.2014: Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech industries, Pharma-Biotech Product and Company Valuation with Dr. Patrik Frei!
Jobs
- Ph.D. position in pancreatic beta-cell research at Third Faculty of Medicine, Charles University, Prague, Czech Republic Project: Regulation of Beta-cell function and viability in relation to type 2 diabetes...
- Ph.D. position in pancreatic beta-cell research at Third Faculty of Medicine, Charles University, Prague, Czech Republic Project: Pancreatic beta-cell and pollutants: the effect of pollutants on viability and function of...
- “Postdoctoral position” at the Department of Cell Nucleus Plasticity The Institute of Experimental Medicine of the Czech Academy of Sciences, Department of the Cell...
Gate2Biotech - Biotechnology portal introduction
Having the status of the official portal for Czech biotechnology, Gate2Biotech serves to biotechnology companies, suppliers, investors, institutions, students and general public interested in biotechnology.
The portal is dedicated to the following subjects: plant and animal ...
- unites biotechnology community
- produces biotechnology report
- completes biotech database
- monitors latest news in biotechnology
- encourages innovative ideas
- searches investors
- facilitate worldwide awareness of biotechnology
